Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 5
2004 6
2005 6
2006 4
2007 9
2008 7
2009 11
2010 15
2011 14
2012 17
2013 12
2014 13
2015 10
2016 10
2017 12
2018 15
2019 12
2020 12
2021 17
2022 6
2023 11
2024 9
2025 10
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
siRNA and RNAi optimization.
Alagia A, Eritja R. Alagia A, et al. Among authors: eritja r. Wiley Interdiscip Rev RNA. 2016 May;7(3):316-29. doi: 10.1002/wrna.1337. Epub 2016 Feb 2. Wiley Interdiscip Rev RNA. 2016. PMID: 26840434 Review.
G-quadruplex nucleic acids.
Eritja R, Mergny JL, Montesarchio D, Spindler L, Webba da Silva M. Eritja R, et al. J Nucleic Acids. 2010 Aug 10;2010:147650. doi: 10.4061/2010/147650. J Nucleic Acids. 2010. PMID: 20814544 Free PMC article. No abstract available.
siRNA Modified with 2'-Deoxy-2'-C-methylpyrimidine Nucleosides.
Dellafiore M, Aviñó A, Alagia A, Montserrat JM, Iribarren AM, Eritja R. Dellafiore M, et al. Among authors: eritja r. Chembiochem. 2018 Jul 4;19(13):1409-1413. doi: 10.1002/cbic.201800077. Epub 2018 May 30. Chembiochem. 2018. PMID: 29656613
Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.
González-Martínez I, Cerro-Herreros E, Carrascosa-Sàez M, García-Rey A, Piqueras-Losilla D, Colom-Rodrigo A, Moreno N, Chakraborty M, Huguet-Lachon A, González-Barriga A, Naldaiz-Gastesi N, Dehesa M, Díaz-Maqueda A, Barquero N, Varela MA, López de Munain A, Eritja R, Gourdon G, López-Castel A, Pérez-Alonso M, Llamusi B, Artero R. González-Martínez I, et al. Among authors: eritja r. Am J Hum Genet. 2026 Mar 5;113(3):529-547. doi: 10.1016/j.ajhg.2026.01.016. Epub 2026 Feb 20. Am J Hum Genet. 2026. PMID: 41722569 Free PMC article.
Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticles.
Voltà-Durán E, Serna N, Sánchez-García L, Aviñó A, Sánchez JM, López-Laguna H, Cano-Garrido O, Casanova I, Mangues R, Eritja R, Vázquez E, Villaverde A, Unzueta U. Voltà-Durán E, et al. Among authors: eritja r. Acta Biomater. 2021 Jan 1;119:312-322. doi: 10.1016/j.actbio.2020.11.018. Epub 2020 Nov 12. Acta Biomater. 2021. PMID: 33189955
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach.
Mahmoodi Chalbatani G, Dana H, Gharagouzloo E, Grijalvo S, Eritja R, Logsdon CD, Memari F, Miri SR, Rad MR, Marmari V. Mahmoodi Chalbatani G, et al. Among authors: eritja r. Int J Nanomedicine. 2019 May 2;14:3111-3128. doi: 10.2147/IJN.S200253. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31118626 Free PMC article. Review.
238 results